Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Both treatments for alopecia areata showed similar modest effectiveness.

Nivolumab can cause hair loss as a rare side effect.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

Itraconazole effectively treated a woman's painful skin condition and hair loss.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Valproic acid and isoniazid can interact, causing toxicity, so careful monitoring is needed.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Cyclosporin A vesicles effectively regrow hair and reduce inflammation in alopecia areata.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

A woman experienced hair loss, nail changes, bone marrow suppression, and low blood protein after taking azathioprine.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

A woman developed lupus after taking hydroxyurea for two years.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Oral dutasteride is effective and safe for treating frontal fibrosing alopecia.

Sodium valproate reduced seizures in many patients with resistant epilepsy.

L-cystine and vitamin B6 at high doses prevented hair loss in mice treated with a chemotherapy drug.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

Upadacitinib effectively treated severe hair loss in a child.

Valproic acid and carbamazepine do not change biotin or biotinidase levels but may lower zinc levels, still within normal range.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

A woman recovered from hair loss and skin eruptions after stopping a tuberculosis drug and using steroids.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.